The use of seroneutralisation techniques is the first concrete step toward the replacement of the mouse challenge test and its derivatives for the batch testing of rabies vaccines
References
1.
Anon. (2010). Monograph 01/2010:0451. Rabies vaccine (inactivated) for veterinary use. In European Pharmacopoeia, 7th edition, pp. 934–936. Strasbourg, France: Council of Europe.
2.
BrucknerL., CusslerK., HalderM., BarratJ., CastleP., DuchowK., GatewoodD.M., GibertR., GroenJ., KnappB., LevisR., MilneC., ParkerS., StunkelK., VisserN., & VolkersP. (2003). Three Rs approaches in the quality control of inactivated rabies vaccines. The report and recommendations of ECVAM Workshop 48. ATLA31, 429–454.
3.
KrämerB., BrucknerL., DaasA., & MilneC. (2010). Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. Pharmeuropa Bio & Scientific Notes2010(2), 37–55.
4.
KrämerB., SchildgerH., Behrensdorf-NicolH.A., HanschmannK.M., & DuchowK. (2009). The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines. Biologicals37, 119–126.
5.
ServatA., KempffS., LabadieA., ScherefferJ.L., BoueF., & CliquetF. (2008). In vivo potency tests of rabies inactivated vaccines for veterinary use: A 2-year retrospective analysis of data according to the criteria of the European Pharmacopoeia. Pharmeuropa20, 655–664.
6.
StokesW., McFarlandR., Kulpa-EddyJ., GatewoodD., LevisR., HalderM., PulleG., KojimaH., CaseyW., GaydamakaA., MillerT., BrownK., LewisC., ChapsalJ.M., BrucknerL., GairolaS., KamphuisE., RupprechtC.E., WunderliP., McElhinneyL., De MattiaF., GamohK., HillR., ReedD., DoellingV., JohnsonN., AllenD., RinckelL., & JonesB. (2012). Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forward. Biologicals40, 369–381.
